Español
Since 2015, the International Day of Women and Girls in Science has been celebrated every February 11.. Proclaimed by the UN, the main objective of this day is to achieve greater participation and inclusion of women and girls in the world of science and technology and break the gender gap that exists in some countries. […]
Category Archives: Noticias
20
Jan
Jan
The last few years have been a true revolution in terms of discoveries and initiatives linked to the world of oligonucleotides, and all eyes and hopes continue to focus in the same direction in the new year 2023. It is clear that the research being carried out in the scientific world is yielding results. In […]
28
Dec
Dec
In the last days of the year, it is time to review everything we have done so far and plan for the coming months. The year 2022 has been very special for Oligofastx, because after the start date in October 2021 and the final resolution of CDTI on December 28, 2021, the project has become […]
16
Dec
Dec
There is no doubt that oligonucleotide therapies aimed at providing answers and improving the quality of life of patients with certain rare diseases, which still have no solution, are a hopeful prospect. The path, already started with numerous initiatives, Oligofastx among them, is also a reality. But much research remains to be done, not only […]
28
Nov
Nov
The Oligofastx project covers the different phases of the development of oligonucleotide-based therapies, from design to production, and this is one of the reasons why the consortium is made up of seven companies, each specializing in different phases of the process. Today we talk about solid-phase synthesis. Oligonucleotides are short chains of different “building blocks” […]
25
Nov
Nov
OLIGOFASTX follows with great interest all the recent advances in the work with oligonucleotides, not only in terms of new lines of research, but also with respect to all the applications that are being developed close to the market. Because it is our ultimate goal and our objective: to provide solutions to diseases that do […]
21
Jul
Jul
The project, subsidised by the CDTI with 5.4 million euros and a final budget of 7.4 million euros, was submitted to the call for Science and Innovation Missions in the framework of the Recovery, Transformation and Resilience Plan. Madrid, 2 February 2022. The OLIGOFASTX project, led by Sylentis, S.A., “Grupo PharmaMar” (MSE:PHM), brings together 7 […]